Thomas R Fritsche
Overview
Explore the profile of Thomas R Fritsche including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
142
Citations
2225
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Legenza L, McNair K, Gao S, Lacy J, Olson B, Fritsche T, et al.
Sci Rep
. 2023 May;
13(1):7122.
PMID: 37130877
The global threat of antimicrobial resistance (AMR) varies regionally. This study explores whether geospatial analysis and data visualization methods detect both clinically and statistically significant variations in antibiotic susceptibility rates...
2.
Ortiz D, Legenza L, Olson B, Knapp C, Killian S, Meece J, et al.
Comp Immunol Microbiol Infect Dis
. 2022 Sep;
89:101880.
PMID: 36116273
Global spread of antimicrobial multidrug resistance (MDR) in human and veterinary medicine relies upon diagnostics, surveillance and stewardship to guide mitigation. Utilizing surveillance of fecal samples from our service area...
3.
Sfeir M, Meece J, Theel E, Granger D, Fritsche T, Steere A, et al.
J Clin Microbiol
. 2022 Apr;
60(5):e0252821.
PMID: 35418241
Modified two-tiered testing (MTTT) algorithms for Lyme disease (LD), which involve the sequential use of orthogonal enzyme immunoassays (EIAs) without immunoblotting, are acceptable alternatives to standard two-tiered testing (STTT; EIA...
4.
Fritsche T, Anderson J, Bassi D, Hall M, Boyle T, Meece J
Ear Nose Throat J
. 2021 Mar;
102(4):NP157-NP160.
PMID: 33683980
Otolaryngologic manifestations of infection with species are extremely rare and restricted geographically to recognized endemic regions. Here, we describe a case of laryngeal blastomycosis that presented as slowly progressive dysphonia....
5.
Brown-Elliott B, Fritsche T, Olson B, Vasireddy S, Vasireddy R, Iakhiaeva E, et al.
Am J Clin Pathol
. 2019 Jul;
152(4):527-536.
PMID: 31314059
Objectives: This multicenter study's aim was to assess the performance of two commercially available matrix-assisted laser desorption/ionization time of flight mass spectrometry systems in identifying a challenge collection of clinically...
6.
Frost H, Fritsche T, Hall M
J Pediatr
. 2018 Dec;
206:268-273.e1.
PMID: 30528760
Objective: To evaluate the epidemiology, clinical features, and antibiotic prescribing patterns for nongroup A streptococci (NGAS) in children. Study Design: Throat cultures obtained for pharyngitis were assessed at a large...
7.
Koester T, Meece J, Fritsche T, Frost H
Clin Med Res
. 2018 Sep;
16(3-4):66-68.
PMID: 30166498
Lyme disease and infectious mononucleosis are common illnesses that share similar clinical presentations. Significant cross-reactivity is known to occur between Lyme and EBV serologic assays complicating the diagnosis. To date,...
8.
Thomm A, Schotthoefer A, Dupuis 2nd A, Kramer L, Frost H, Fritsche T, et al.
mSphere
. 2018 Jan;
3(1).
PMID: 29359181
Powassan virus (POWV) is an emerging tick-borne arbovirus presenting a public health threat in North America. POWV lineage II, also known as deer tick virus, is the strain of the...
9.
Shukla S, Ye Z, Sandberg S, Reyes I, Fritsche T, Keifer M
PLoS One
. 2017 Aug;
12(8):e0183898.
PMID: 28850578
Allergic and autoimmune diseases had been attributed to lack of exposure to biodiversity, an important factor in regulating immune homeostasis in a healthy host. We posit that the microbiome of...
10.
Frost H, Schotthoefer A, Thomm A, Dupuis 2nd A, Kehl S, Kramer L, et al.
Emerg Infect Dis
. 2017 Jul;
23(8):1384-1388.
PMID: 28726610
Powassan virus (POWV) lineage II is an emerging tickborne flavivirus with an unknown seroprevalence in humans. In a Lyme disease-endemic area, we examined the seroreactivity to POWV in 2 patient...